Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

Hamlet BioPharma AB (publ): The HAMLET project featured in Cancerfonden's Christmas Campaign

Hamlet BioPharma

The Swedish Cancer Society, Cancerfonden, is a powerful and important research support organization in Sweden. Based mainly on donations, Cancerfonden and its quality review system, has ensured that cancer research has an independent, quality-based funding source. This support from Cancerfonden has allowed a diverse flora of cancer research projects to thrive and develop scientifically and in some cases clinically.

The Hamlet group at Lund University has received funding from Cancerfonden since the discovery of the HAMLET molecule and this continued support has been crucial for the scientific achievements that have been made, from discovery to the clinical studies and treatment of cancer.

This year The Christmas Campaign of Cancerfonden features the HAMLET project as an example of their success and a vehicle for the continued support through donations from the public.

We would like to draw your attention to this opportunity to support cancer research.

https://www.cancerfonden.se/stod- oss/kampanj?c_rid=60gt0q4n019ftmtSaDg- 977537727%7C148365500&utm_source=symplify&utm_medium=email&utm_campai gn=kampanjkommunikation&utm_content=edr_december2025&verifyEmailToken =false

We wish everyone Happy Holidays

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.